CoChat

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial

Open access
Papamargaritis, Dimitris, Al-Najim, Werd, Lim, Jonathan, Crane, James, Lean, Mike, le Roux, Carel, McGowan, Barbara, O'Shea, Donal, Webb, David, Wilding, John, Davies, Melanie J · 2020 · BMJ Open
Cited by 13

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Introduction: In the UK and Ireland, severe and complex obesity is managed in specialist weight management services (SWMS), which provide multicomponent lifestyle interventions to support weight loss, and use of medication if available. Liraglutide 3 mg (LIRA 3 mg) is an effective weight-loss medication, but weight loss in individual patients is variable, and its efficacy has not been assessed in SWMS. This study aims to investigate whether a targeted prescribing pathway for LIRA 3 mg with multiple prespecified stopping rules could help people with severe obesity and established complications achieve ≥15% weight loss in order to determine whether this could be considered a clinically effective and cost-effective strategy for managing severe and complex obesity in SWMS. Methods and analysis: In this 2-year, multicentre, open-label, real-world randomised controlled trial, 384 adults with severe and complex obesity (defined as body mass index ≥35 kg/m 2 plus either prediabetes, type 2 diabetes, hypertension or sleep apnoea) will be randomised via a 2:1 ratio to receive either standard SWMS care (n=128) or standard SWMS care plus a targeted prescribing pathway for LIRA 3 mg with prespecified stopping rules at 16, 32 and 52 weeks (n=256). The primary outcome is to compare the proportion of participants achieving a weight loss of ≥15% at 52 weeks with a targeted prescribing pathway versus standard care. Secondary outcomes include a comparison of (1) the weight loss maintenance at 104 weeks and (2) the budget impact and cost effectiveness between the two groups in a real-world setting. Ethics and dissemination: The Health Research Authority and the Medicines and Healthcare products Regulatory Authority in UK, the Health Products Regulatory Authority in Ireland, the North West Deanery Research Ethics Committee (UK) and the St Vincent’s University Hospital European Research Ethics Committee (Ireland) have approved the study. The findings of the study will be published in peer-reviewed journals. Trial registration number: ClinicalTrials.gov—Identifier: NCT03036800 . European Clinical Trials Database—Identifier: EudraCT Number 2017-002998-20.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2019-034137

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 14

  1. Welbourn, 2018, Commissioning guidance for weight assessment and management in adults and children with severe complex obesity, Obes Rev, 19, 14, 10.1111/obr.12601 · DOI · Paper page
  2. Ahmad, 2014, Eligibility for bariatric surgery among adults in England: analysis of a national cross-sectional survey, JRSM Open, 5, 204253331351247, 10.1177/2042533313512479 · DOI
  3. 10.1001/jama.283.14.1829 · DOI · Paper page
  4. 10.1093/pubmed/fdr033 · DOI · Paper page
  5. Wilding, 2018, Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK, Clin Obes, 8, 211, 10.1111/cob.12248 · DOI · Paper page
  6. 10.1111/cob.12066 · DOI
  7. Alkharaiji, 2019, Tier 3 specialist weight management service and pre-bariatric multicomponent weight management programmes for adults with obesity living in the UK: a systematic review, Endocrinol Diab Metab, 2, 10.1002/edm2.42 · DOI
  8. 10.7326/0003-4819-119-7_Part_2-199310011-00012 · DOI · Paper page
  9. 10.2337/dc15-1081 · DOI · Paper page
  10. Montesi, 2016, Long-Term weight loss maintenance for obesity: a multidisciplinary approach, Diabetes Metab Syndr Obes, 9, 37
  11. 10.1111/bcp.12578 · DOI · Paper page
  12. Hughes, 2015, The rewards and challenges of setting up a tier 3 adult weight management service in primary care, Br J Obes, 1, 25
  13. 10.1056/NEJMoa1411892 · DOI · Paper page
  14. 10.7326/0003-4819-158-3-201302050-00583 · DOI · Paper page

Cited by

See all 13

Metadata

Authors
Papamargaritis, D., Al-Najim, W., Lim, J., Crane, J., Lean, M., le Roux, C., McGowan, B., O'Shea, D., Webb, D., Wilding, J., & Davies, M. J.
Venue
BMJ Open
Publisher
BMJ
Published
2020-02
Volume
10
Issue
2
Pages
e034137
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3005613123
Cited by
13
References
12
FWCI
0.61
Type
journal article
Language
en
Open access
gold
Funders
Novo Nordisk

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.